Pestronk Lab
Alan Pestronk, MD
Focused on neuromuscular disorders through clinical and research efforts. The lab investigates conditions like myopathy, neuropathy and myasthenia gravis, emphasizing neuroimmunology, aging and molecular mechanisms to improve diagnosis and treatment.
Learn more on the Neuromuscular Disease Center website »
Principal investigator
Our team
Recent publications
- A randomized, double-blind, placebo-controlled study of losmapimod in patients with facioscapulohumeral muscular dystrophy: Results of the REACH studyon behalf of the REACH Investigators, Sep 2026, In: Journal of neuromuscular diseases. 13, 5, p. 1049-1064 16 p.Research output: Contribution to journal › Article › peer-review
- Identification of prognostic biomarkers in a large cohort of patients with LGMD R2The Jain COS Consortium, Jun 2026, In: Journal of Neurology. 273, 6, 344.Research output: Contribution to journal › Article › peer-review
- Integrating Serum Neurofilament Light Chain Into Amyotrophic Lateral Sclerosis Diagnostic CriteriaSmith, S. E., Miller, T. M., Atkinson, A., Pestronk, A. & Bucelli, R. C., Jun 2026, In: Muscle and Nerve. 73, 6, p. 990-995 6 p.Research output: Contribution to journal › Article › peer-review
- Progressive Myopathy and Respiratory Failure in a 7-Year-Old Boy With m.3251A>G MT-TL1 Mutation.Hoang, D., Pestronk, A. & Kafaie, J., Mar 2026, In: Journal of clinical neuromuscular disease. 27, 3, p. 89-95 7 p.Research output: Contribution to journal › Article › peer-review
- Chronic Immune Peripheral Nerve Myelinopathies—A Plea for PrecisionCrayle, J. & Pestronk, A., Dec 8 2025, In: JAMA Neurology. 82, 12, p. 1207-1208 2 p.Research output: Contribution to journal › Short survey › peer-review